Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)
Clinical trial NCT03346434 · COMPLETED
Trial details
- NCT number
- NCT03346434
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2021-07-08
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.